New Horizons in Dementia Detection & Treatment September 05, 2024

From new blood tests that can make diagnosing Alzheimer’s disease faster, easier, and less expensive to new FDA-approved monoclonal antibody (mAbs) treatments that may stop or delay the progression of Alzheimer’s disease, experts are cautious but hopeful about the future of diagnosing and treating cognitive decline. What does this mean for you as an older adult, loved one, or care professional, and what can you actually access today?

Join Sunday Health’s dementia neurologist, Dr. Amy Sanders, for this interactive live discussion, open to everyone. Learn about this new era in dementia care and hear how these advancements might impact your life or practice.

Featuring: Dr. Amy Sanders, MD, FAAN | Dementia Neurologist at Sunday Health